The story of D-Wave Quantum is no longer just about quantum computing’s long shot—it has become a tale of two balance sheets. On one side, the company sits on more than €884 million in cash and marketable securities, the highest cash pile in its history, after a restructuring last year that absorbed Quantum Circuits Inc. On the other, it continues to burn through capital as it tries to prove that its dual-platform approach—quantum annealing and gate-model systems—can generate real commercial revenue. The tension between those two realities will be on full display at the Qubits Europe 2026 conference in London on June 18, where D-Wave plans to showcase live demonstrations of Fortune-2000 clients using its technology in operational processes.
The immediate catalyst for the stock’s recent surge came from Washington. Under the CHIPS and Science Act, the U.S. government committed up to $100 million to D-Wave, a nod that analysts say validates both of its technology platforms. That announcement triggered a sector-wide rally and pushed D-Wave’s shares to a 30-day gain of over 22% in the primary source article, though the secondary source reports a slightly lower 15% gain over the same period. The discrepancy likely reflects different closing points, but the broader trend is clear: the stock has more than doubled from its 52-week low of €11.12 in March, closing at €20.20 on Friday, before adding nearly 6% on Monday to reach €21.39.
Yet the buying frenzy gave company insiders an opportune moment to reduce their holdings. CFO John Markovich sold roughly 328,000 shares in late May for about $9.1 million, followed by additional sales in early June, including a block at a weighted average price of $26.24 that netted around $1.34 million. CEO Alan Baratz also parted with shares worth approximately $18 million. The company has framed these transactions as tax-planning moves, and Baratz still holds a substantial stake. With 15 analysts covering the stock—64% at “Strong Buy” and 36% at “Buy”—the insider selling has not shaken Wall Street’s conviction. Rosenblatt Securities reiterated its buy rating with a $43 price target on June 11, arguing the government investment de-risks D-Wave’s roadmap. Stifel holds a $35 target, and Canaccord Genuity trimmed its target from $43 to $41 but kept a “Buy.” The consensus target sits at $31.48, implying roughly 56% upside from Friday’s close.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Technically, the stock is in a transitional zone. It closed at €20.20, about 8% above its 50-day moving average of €18.72, but still just below the 200-day average of €20.88. The relative strength index at 47 signals neutral territory—neither overbought nor oversold. Meanwhile, the 30-day annualized volatility of 139% underscores that this remains a high-octane name, prone to sharp swings. From its October 2025 high of €38.48, the stock is still down almost 48%, a gap that the analyst consensus suggests can be closed if the company delivers on its “Quantum-as-a-Service” model and concrete contracts, such as the €20 million system purchase from Florida Atlantic University.
The London conference will be the next critical datapoint. For a sector under constant pressure to demonstrate commercial relevance, D-Wave needs to show that its annealing systems are not just experimental tools but working infrastructure. With a market cap of €7.6 billion, the company has clearly outgrown its micro-cap label. The question now is whether the narrative shift from research project to industrial supplier can hold its momentum—and whether insider selling is a simple matter of tax planning or an early sign of doubts about the speed of that transition.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from June 19 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 19.
D-Wave Quantum: Buy or sell? Read more here...
